Ginsenoside Rb1 attenuates methamphetamine (METH)-induced neurotoxicity through the NR2B/ERK/CREB/BDNF signalings in vitro and in vivo models
| Autor: | Liu Liu, Yanxia Peng, Qi Li, Baoyu Shen, Yi Tan, Huijie Zhang, Shuwei Zhang, Shucheng Lin, Genmeng Yang, Yue Xu, Xiaofeng Zeng, Chan Wang, Juan Li, Yuanyuan Li, Gang Lu |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
MAPK/ERK pathway
biology Chemistry Neurotoxicity Meth Pharmacology Methamphetamine Nucleus accumbens medicine.disease CREB Biochemistry Genetics and Molecular Biology (miscellaneous) Conditioned place preference chemistry.chemical_compound nervous system Complementary and alternative medicine medicine biology.protein Viability assay Biotechnology medicine.drug |
| Zdroj: | Journal of Ginseng Research. 46:426-434 |
| ISSN: | 1226-8453 |
| Popis: | Aim This study investigates the effects of ginsenoside Rb1 (GsRb1) on methamphetamine (METH)-induced toxicity in SH-SY5Y neuroblastoma cells and METH-induced conditioned place preference (CPP) in adult Sprague-Dawley rats. It also examines whether GsRb1 can regulate these effects through the NR2B/ERK/CREB/BDNF signaling pathways. Methods SH-SY5Y cells were pretreated with GsRb1 (20 μM and 40 μM) for 1 h, followed by METH treatment (2 mM) for 24 h. Rats were treated with METH (2 mg/kg) or saline on alternating days for 10 days to allow CPP to be examined. GsRb1 (5, 10, and 20 mg/kg) was injected intraperitoneally 1 h before METH or saline. Western blot was used to examine the protein expression of NR2B, ERK, P-ERK, CREB, P-CREB, and BDNF in the SH-SY5Y cells and the rats' hippocampus, nucleus accumbens (NAc), and prefrontal cortex (PFC). Results METH dose-dependently reduced the viability of SH-SY5Y cells. Pretreatment of cells with 40 μM of GsRb1 increased cell viability and reduced the expression of METH-induced NR2B, p-ERK, p-CREB and BDNF. GsRb1 also attenuated the expression of METH CPP in a dose-dependent manner in rats. Further, GsRb1 dose-dependently reduced the expression of METH-induced NR2B, p-ERK, p-CREB, and BDNF in the PFC, hippocampus, and NAc of rats. Conclusion GsRb1 regulated METH-induced neurotoxicity in vitro and METH-induced CPP through the NR2B/ERK/CREB/BDNF regulatory pathway. GsRb1 could be a therapeutic target for treating METH-induced neurotoxicity or METH addiction. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|